Your session is about to expire
← Back to Search
Cabozantinib + Pembrolizumab for Bladder Cancer (PemCab Trial)
PemCab Trial Summary
This trial is testing a combination of two drugs to treat people with urothelial carcinoma who can't take cisplatin. They'll look at how well the drugs work, how long people live, and if there are any side effects.
PemCab Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPemCab Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PemCab Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the most recent findings from research on Pembrolizumab?
"City of Hope was the first to study pembrolizumab back in 2010 and there have been 305 completed trials since. Right now, 1108 more studies are recruiting patients with a significant number taking place in Salt Lake City, Utah."
Pembrolizumab has been linked to several fatalities, is this medication safe for human use?
"Pembrolizumab has received a Phase 2 safety rating, meaning that while there is evidence suggesting it is safe, more data needs to be collected regarding its efficacy."
What are some of the main reasons that Pembrolizumab is given to patients?
"Pembrolizumab is frequently used to treat unresectable melanoma. However, it can also be helpful for patients with microsatellite instability high, those at a high risk of disease recurrence, and other conditions."
Are people still being asked to participate in this clinical trial?
"That is correct. As of now, the clinical trial indicated on clinicaltrials.gov is looking for patients to participate. This study was first posted on September 18th, 2018 and has since been updated on June 9th, 2022. A total of 39 patients are needed from 3 different locations."
How many people are volunteering for this research project?
"Yes, the information on clinicaltrials.gov suggests that this trial is currently searching for patients. The trial was first posted on 9/18/2018 and was last edited on 6/9/2022. The clinical trial is looking for 39 patients between 3 sites"
Share this study with friends
Copy Link
Messenger